Gene Therapy Stops Bleeding in Hemophilia Patients
By infusing hemophilia sufferers with safe, redesigned viruses, it’s possible to get their livers making clotting agents that are otherwise missing from their body.
Patients with hemophilia B lack a gene that helps create factor IX, a protein that clots blood, making it difficult for even small bleeds to stop. A promising gene therapy developed by Spark Therapeutics promises to solve that by administering an infusion of viruses carrying the missing factor IX gene. In a handful of patients, early results appeared to be promising (see “Gene Therapy Is Curing Hemophilia”).
Now, a modestly sized trial suggests that Spark may really be onto something. In results published in the New England Journal of Medicine, 10 patients received viruses designed to deliver the missing gene to their livers. Eighteen months after the treatment, on average their livers made 34 percent of the normal level of the clotting agent. That may sound low, but it was enough for nine patients to have no bleeding, and eight didn’t require regular injections of clotting agent.
Some question marks still hang over the therapy. First, the trial is still small, and larger tests will be required before the treatment really proves itself. Another major concern is how long the effect will last beyond the 18 months of the trial. It’s hoped that it will be a one-time cure, but it might need to be if it’s going to be viable—given the high cost of gene therapies, multiple treatments over a lifetime may not be feasible.
Keep Reading
Most Popular
Geoffrey Hinton tells us why he’s now scared of the tech he helped build
“I have suddenly switched my views on whether these things are going to be more intelligent than us.”
ChatGPT is going to change education, not destroy it
The narrative around cheating students doesn’t tell the whole story. Meet the teachers who think generative AI could actually make learning better.
Meet the people who use Notion to plan their whole lives
The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.
Learning to code isn’t enough
Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.